OAKTREE CAPITAL MANAGEMENT LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,483,000
-58.7%
1,675,000
-57.0%
0.02%
-61.5%
Q4 2021$3,590,000
+2.5%
3,891,000
-1.6%
0.04%
-20.4%
Q3 2021$3,503,000
-30.8%
3,954,000
-27.0%
0.05%
-27.9%
Q2 2021$5,060,000
-3.2%
5,414,000
-6.3%
0.07%
-6.8%
Q1 2021$5,227,000
+88.3%
5,780,000
+81.2%
0.07%
+52.1%
Q4 2020$2,776,0003,189,0000.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$22,713,0005.56%
SILVERBACK ASSET MANAGEMENT LLC 7,707,000$6,912,0000.94%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,615,000$31,948,0000.74%
DeepCurrents Investment Group LLC 12,521,000$11,079,0000.34%
AGF Investments LLC 4,000,000$3,502,0000.29%
WATER ISLAND CAPITAL LLC 2,250,000$2,014,0000.10%
L & S Advisors Inc 935,000$829,0000.10%
Sculati Wealth Management, LLC 200,000$177,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 3,192,000$2,816,0000.06%
Teton Advisors, Inc. 400,000$354,0000.06%
View complete list of PARATEK PHARMACEUTICALS INC shareholders